Next Article in Journal
In Silico Molecular Docking and In Vivo Validation with Caenorhabditis elegans to Discover Molecular Initiating Events in Adverse Outcome Pathway Framework: Case Study on Endocrine-Disrupting Chemicals with Estrogen and Androgen Receptors
Next Article in Special Issue
Indole-Based Hydrazones Containing A Sulfonamide Moiety as Selective Inhibitors of Tumor-Associated Human Carbonic Anhydrase Isoforms IX and XII
Previous Article in Journal
Physiological Diversity of Spitsbergen Soil Microbial Communities Suggests Their Potential as Plant Growth-Promoting Bacteria
Open AccessArticle

Novel 8-Substituted Coumarins That Selectively Inhibit Human Carbonic Anhydrase IX and XII

1
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Yeditepe University, Kayisdagi Cad., 34755 Istanbul, Turkey
2
NEUROFARBA Department, Pharmaceutical and Nutraceutical Section, University of Florence, 50019 Sesto Fiorentino, Italy
3
Department of Pharmacy, University of Pisa, 56126 Pisa, Italy
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2019, 20(5), 1208; https://doi.org/10.3390/ijms20051208
Received: 15 February 2019 / Revised: 4 March 2019 / Accepted: 6 March 2019 / Published: 10 March 2019
(This article belongs to the Special Issue Protease and Carbonic Anhydrase Inhibitors, II)
A novel series of 8-substituted coumarin-based compounds, characterized by the presence of alkylpiperazine and arylpiperazine chains, were synthesized and tested for their inhibitory activity against four human carbonic anhydrase (hCA) isoforms. All compounds displayed nanomolar potency against the cancer-related hCA IX and hCA XII; moreover, they were shown to be devoid of any inhibitory activity toward the cytosolic hCA I and hCA II up to 10 µM concentration in the assay system. Therefore, the synthesized coumarin ligands demonstrated to be potent and selective hCA IX/XII inhibitors, and were shown to be as potent as the reference inhibitor acetazolamide against hCA XII, with single-digit nanomolar Ki values. Molecular modeling studies provided a rationale for explaining the selectivity profile of these non-classic hCA inhibitors and their interactions with the enzymes, according to their specific mechanism of action, thus paving the way for future structure-based lead optimization studies. View Full-Text
Keywords: carbonic anhydrase inhibitor; metalloenzymes; coumarins; docking; molecular modeling carbonic anhydrase inhibitor; metalloenzymes; coumarins; docking; molecular modeling
Show Figures

Graphical abstract

MDPI and ACS Style

Buran, K.; Bua, S.; Poli, G.; Önen Bayram, F.E.; Tuccinardi, T.; Supuran, C.T. Novel 8-Substituted Coumarins That Selectively Inhibit Human Carbonic Anhydrase IX and XII. Int. J. Mol. Sci. 2019, 20, 1208.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop